H S Duong1, Q-Z Zhang, A D Le, A P Kelly, R Kamdar, D V Messadi. 1. Division of Oral Biology and Medicine, University of California Los Angeles, School of Dentistry, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Abstract
BACKGROUND: Keloid pathogenesis involves an altered balance of extracellular matrix metabolism, mainly accumulation of type I collagen. This could be due to excessive synthesis or decreased degradation of matrix, or a combination of both processes. Prolidase, an imidodipeptide-cleaving cytosolic enzyme, plays an important role in the collagen catabolic process by recycling proline for collagen synthesis. Collagen accumulation in keloids is due to an imbalance in the steady state of collagen turnover. OBJECTIVES: To investigate prolidase activity and its role in the steady state of collagen turnover between normal skin and keloid tissue and their derived fibroblasts. METHODS: Ten sets of keloid and normal skin tissues and their derived fibroblasts were employed. Measurements were made of tissue prolidase activity, free proline level, and concentrations of the collagen synthesis product aminoterminal propeptide of type I procollagen (PINP) and the collagen degradative product carboxyterminal telopeptide of type I collagen (ICTP). Also, synthesis of collagens type I and III and matrix metalloproteinases 1 and 2 was investigated using Western blot analysis. RESULTS: Keloid tissues had a significant increase in prolidase activity, up to fourfold that in normal skin. The elevated prolidase activity was accompanied by an increase in tissue PINP and ICTP concentrations in keloid; in addition, the collagen turnover index (PINP/ICTP) was higher in keloids. CONCLUSIONS: The combination of elevated prolidase activity and associated higher collagen synthesis to degradation ratio in keloids suggests a possible metabolic process for the excessive accumulation of type I collagen in keloids.
BACKGROUND: Keloid pathogenesis involves an altered balance of extracellular matrix metabolism, mainly accumulation of type I collagen. This could be due to excessive synthesis or decreased degradation of matrix, or a combination of both processes. Prolidase, an imidodipeptide-cleaving cytosolic enzyme, plays an important role in the collagen catabolic process by recycling proline for collagen synthesis. Collagen accumulation in keloids is due to an imbalance in the steady state of collagen turnover. OBJECTIVES: To investigate prolidase activity and its role in the steady state of collagen turnover between normal skin and keloid tissue and their derived fibroblasts. METHODS: Ten sets of keloid and normal skin tissues and their derived fibroblasts were employed. Measurements were made of tissue prolidase activity, free proline level, and concentrations of the collagen synthesis product aminoterminal propeptide of type I procollagen (PINP) and the collagen degradative product carboxyterminal telopeptide of type I collagen (ICTP). Also, synthesis of collagens type I and III and matrix metalloproteinases 1 and 2 was investigated using Western blot analysis. RESULTS: Keloid tissues had a significant increase in prolidase activity, up to fourfold that in normal skin. The elevated prolidase activity was accompanied by an increase in tissue PINP and ICTP concentrations in keloid; in addition, the collagen turnover index (PINP/ICTP) was higher in keloids. CONCLUSIONS: The combination of elevated prolidase activity and associated higher collagen synthesis to degradation ratio in keloids suggests a possible metabolic process for the excessive accumulation of type I collagen in keloids.
Authors: Ibrahim Türkbeyler; Tuncer Demir; Yavuz Pehlivan; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Nurten Aksoy; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat Journal: Inflammation Date: 2012-10 Impact factor: 4.092
Authors: John H Lillvis; Yoshiki Kyo; Gerard Tromp; Guy M Lenk; Ming Li; Qing Lu; Robert P Igo; Natzi Sakalihasan; Robert E Ferrell; Charles M Schworer; Zoran Gatalica; Susan Land; Helena Kuivaniemi Journal: BMC Med Genet Date: 2011-01-19 Impact factor: 2.103
Authors: Francisco Miguel Camacho-Martínez; Elena Rodríguez Rey; Francisco Camacho Serrano; Adriana Wagner Journal: An Bras Dermatol Date: 2013 May-Jun Impact factor: 1.896
Authors: Aldi T Kraja; Daniel I Chasman; Kari E North; Alexander P Reiner; Lisa R Yanek; Tuomas O Kilpeläinen; Jennifer A Smith; Abbas Dehghan; Josée Dupuis; Andrew D Johnson; Mary F Feitosa; Fasil Tekola-Ayele; Audrey Y Chu; Ilja M Nolte; Zari Dastani; Andrew Morris; Sarah A Pendergrass; Yan V Sun; Marylyn D Ritchie; Ahmad Vaez; Honghuang Lin; Symen Ligthart; Letizia Marullo; Rebecca Rohde; Yaming Shao; Mark A Ziegler; Hae Kyung Im; Renate B Schnabel; Torben Jørgensen; Marit E Jørgensen; Torben Hansen; Oluf Pedersen; Ronald P Stolk; Harold Snieder; Albert Hofman; Andre G Uitterlinden; Oscar H Franco; M Arfan Ikram; J Brent Richards; Charles Rotimi; James G Wilson; Leslie Lange; Santhi K Ganesh; Mike Nalls; Laura J Rasmussen-Torvik; James S Pankow; Josef Coresh; Weihong Tang; W H Linda Kao; Eric Boerwinkle; Alanna C Morrison; Paul M Ridker; Diane M Becker; Jerome I Rotter; Sharon L R Kardia; Ruth J F Loos; Martin G Larson; Yi-Hsiang Hsu; Michael A Province; Russell Tracy; Benjamin F Voight; Dhananjay Vaidya; Christopher J O'Donnell; Emelia J Benjamin; Behrooz Z Alizadeh; Inga Prokopenko; James B Meigs; Ingrid B Borecki Journal: Mol Genet Metab Date: 2014-05-09 Impact factor: 4.797
Authors: Rodney K Chan; Lloyd F Rose; Jesse C Wu; David I Tucker; Maren M Chan; Robert J Christy; Robert G Hale; Kai P Leung Journal: Plast Reconstr Surg Glob Open Date: 2015-08-10